Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. [electronic resource]
Producer: 20030916Description: 1072-9 p. digitalISSN:- 0008-543X
- Aged
- Anemia -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Combined Modality Therapy
- Drug Administration Schedule
- Epoetin Alfa
- Erythropoietin -- administration & dosage
- Female
- Hematinics -- administration & dosage
- Hemoglobins -- analysis
- Humans
- Injections, Subcutaneous
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Quality of Life
- Radiotherapy -- adverse effects
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.